3PP4 PDB NFT

Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti- CD20 antibodies

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba

IPFS of NFT metadata:

bafybeigr6ponassyxnmd6mzme2g4jaqqkvjcgixcfifuwo4k2poqmt4gsi/metadata.json

IPFS of structure file:

bafybeicwzbkslkuipsburxaujryb7keuwqtgceslgiyd6glvfkfipcd4f4/3pp4.pdb

MOLNFT PDB v1

NFT id:
75405
PDB ID:
3PP4
Name:
Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti- CD20 antibodies
Keywords:
IMMUNE SYSTEM
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.60

NFT data

MolNFT PDB v1 is The Protein Data Bank database (URL: https://rcsb.org) of protein structures minted as ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne.
(2000) The Protein Data Bank Nucleic Acids Research, 28: 235-242.

MOLNFT 3PP4 research and analysis (ICN3D with VR)

FASTA sequences

>3pp4_H mol:protein length:224 GA101 Fab heavy chain
QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK
>3pp4_L mol:protein length:219 GA101 Fab light chain
DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
>3pp4_P mol:protein length:25 B-lymphocyte antigen CD20
NIYNCEPANPSEKNSPSTQYCYSIQ

References and links

Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 3PP4
TITLE: Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti- CD20 antibodies
DOI: 10.1182/blood-2010-09-305847
AUTHORS: Hopfner, K.-P., Lammens, A.
ACCESSION DATE: 11/24/10
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/3PP4